Showing results (161-170 of 3,079) with videos related to
Sort By:
Pageof 308
Drug Safety|July 9, 2013
Angiotensin-converting enzyme inhibitor treatment and the development of urinary tract infections: a prescription sequence symmetry analysisKoen B Pouwels, Sipke T Visser, H Jens Bos, et al.Drug Safety|January 19, 2013
Benefit-risk assessment of dronedarone in the treatment of atrial fibrillationAhmed M A Adlan, Gregory Y H LipDrug Safety|January 15, 2013
Pharmacovigilance in the Middle East: a survey of 13 arabic-speaking countriesKerry WilburDrug Safety|January 15, 2013
Opportunities to reduce medication regimen complexity: a retrospective analysis of patients discharged from a university hospital in GermanyDiana Witticke, Hanna M Seidling, Kristina Lohmann, et al.Drug Safety|March 1, 2013
A review of pharmacogenetics of adverse drug reactions in elderly peopleMaurizio Cardelli, Francesca Marchegiani, Andrea Corsonello, et al.Drug Safety|March 1, 2013
Estimating renal function to reduce the risk of adverse drug reactionsAndrea Corsonello, Graziano Onder, Silvia Bustacchini, et al.Drug Safety|March 1, 2013
The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic reviewCarlos Chiatti, Silvia Bustacchini, Gianluca Furneri, et al.Drug Safety|March 12, 2013
Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian studyRoberto Leone, Ugo Moretti, Paola D'Incau, et al.Drug Safety|May 1, 2012
Prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in the Netherlands from 1998 to 2008Rikje Ruiter, Loes E Visser, Myrthe P P van Herk-Sukel, et al.Drug Safety|April 5, 2013
Development and Initial Validation of a Patient-Reported Adverse Drug Event QuestionnaireSieta T de Vries, Peter G M Mol, Dick de Zeeuw, et al.Pageof 308